A 19-year-old man with a confirmed pathogenic APC mutation (family history of FAP) undergoes colonoscopy for surveillance. Bowel preparation is excellent. The colonoscopy reveals the finding marked **B** in the diagram — an uninterrupted carpet of hundreds to thousands of small sessile and pedunculated adenomatous polyps covering the entire colonic mucosa with virtually no intervening normal mucosa visible. Several polyps show high-grade dysplasia on histology. Based on this endoscopic finding and clinical presentation, which of the following is the most appropriate next management step?
A. Prophylactic total proctocolectomy with ileal pouch-anal anastomosis (IPAA)
B. Topical ablation therapy (argon plasma coagulation) of the entire colonic mucosa
C. Endoscopic polypectomy of all polyps >10 mm followed by 3-monthly surveillance colonoscopy
D. Repeat colonoscopy in 6 months to assess polyp progression before considering surgery
Explanation
Why Prophylactic total proctocolectomy with IPAA is right
The finding marked B — a confluent carpet of hundreds to thousands of adenomatous polyps involving the entire colonic mucosa with no intervening normal mucosa — is pathognomonic for classic FAP (≥100 colorectal adenomas). This endoscopic appearance, combined with confirmed APC mutation, presence of high-grade dysplasia, and intramucosal carcinoma on histology, meets all criteria for prophylactic proctocolectomy. According to the NCCN Guidelines FAP/AFAP 2024 and Syngal et al. (ACG Guideline 2023), once classic FAP is confirmed with this degree of polyp burden and dysplasia, endoscopic management is futile and prophylactic surgery is mandatory to prevent colorectal cancer. IPAA is preferred in this patient due to dense rectal involvement and dysplasia. This is the standard of care and only definitive management.
Why each distractor is wrong
Endoscopic polypectomy of all polyps >10 mm followed by 3-monthly surveillance: Endoscopic therapy is not feasible or appropriate for the carpet-like polyp burden seen in classic FAP. Attempting piecemeal polypectomy of hundreds to thousands of polyps is technically impossible, time-prohibitive, and carries unacceptable risk of perforation and bleeding. This approach is reserved only for attenuated FAP with <100 polyps and no dysplasia.
Repeat colonoscopy in 6 months to assess polyp progression: Delaying surgery in a patient with confirmed APC mutation, classic FAP phenotype, high-grade dysplasia, and intramucosal carcinoma is inappropriate and dangerous. The cancer risk is imminent. Guidelines mandate prophylactic surgery once classic FAP is established; surveillance without surgery is not an option in this setting.
Topical ablation therapy (argon plasma coagulation) of the entire colonic mucosa: Ablation of the entire colonic mucosa in FAP is not evidence-based and does not reduce cancer risk. It is technically impractical, does not address the underlying genetic predisposition, and leaves residual adenomatous tissue at risk for malignant transformation. It is not a recognized management strategy in any guideline.
High-YieldNEET PG
The confluent carpet of polyps covering the entire mucosa with no intervening normal mucosa is the single most specific endoscopic hallmark of classic FAP and mandates prophylactic proctocolectomy, not endoscopic management.
Syngal S. ACG Guideline: Genetic Testing and Management of Hereditary GI Cancer Syndromes 2023 update. NCCN Guidelines FAP/AFAP 2024.
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
